Aged care AI company InteliCare saw distributors increase by almost half in the December quarter
Health & Biotech
Health & Biotech
Link copied to
Special Report: InteliCare has increased its distributors, through either agents or resellers by 45pc in December 2020.
InteliCare (ASX:ICR), an Australian technology company specialising in artificial intelligence products for use in the aged care and health industries, has released its December 2020 quarterly update, boasting a sharp increase in distribution channels.
Sixteen entities across Australia now resell or distribute InteliCare’s products.
Eremea Home Care Services made an initial order valued at over $150,000 late last year, and the Company also executed an agreement with Technology for Ageing and Disability ACT Inc (TADACT).
While InteliCare’s stockists have increased, the company also launched its very own B2C platform to drive direct-to-consumer sales which has continued to increase.
The company’s brand and marketing strategies, as well as its channel plan have also been given a revamp, with more consumer marketing efforts said to be taking off in Q1 2021.
InteliCare has also been busy in the lab, having completed the development of an advanced robot simulator called COLT (Container Based Load Lending) to run virtually unlimited virtual ‘robotic’ households.
The company is using this asset to simulate real client data for testing and training purposes.
InteliCare also reports the completion of a new vital sign monitoring system, tipped to officially launch in early Q1 2021.
Using smart health devices such as Fitbit, residents and carers will be able to track 10 new health indicators such as blood pressure, blood glucose, weight, activity (steps), respiration, blood oxygenation and heart rate.
InteliCare’s CEO Jason Waller says their review on the December 2020 quarter puts them in good stead for the year to come.
“We’ve been extremely pleased with InteliCare’s progress thus far. The pandemic and the Royal Commission into Aged Care has put us at the forefront of the aged care conversation and we continue to be the best and most viable monitoring solution for Australia’s elderly,” said Waller.
“We’re continuing to focus our efforts on direct to consumer sales and marketing and will be looking to expand our distribution channels even further this year.
“With the imminent launch of our new vital sign monitor, we’re confident we’ll be in a good place for growth in 2021.”
Last year InteliCare’s Jason Waller spoke to Dr. Nigel Finch on Stockhead’s StockTalk podcast, discussing rapidly accelerating technology in the aged care industry. The Company launched its B2C platform in October 2020.
This article was developed in collaboration with InteliCare, a Stockhead advertiser at the time of publishing.
This article does not constitute financial product advice. You should consider obtaining independent advice before making any financial decisions.